fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Quinagolide HCL

All products: Limited Use (codes 405)

Norprolac · DIN 02223775 · 0.15 mg · tablet

Limited Use, Reason for Use code 405 required; Health Canada lists this DIN as Cancelled post market since 2021-06-02 — choose a marketed DIN from the same-category list.Discontinued June 2, 2021 · checked November 17, 2026
StatusLimited Use, Reason for Use code 405 required; Health Canada lists this DIN as Cancelled post market since 2021-06-02 — choose a marketed DIN from the same-category list.
Write on scriptReason for Use code 405 (criteria below); Health Canada lists this DIN as Cancelled post market since 2021-06-02 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 405
Reason for Use code 405 For the treatment of hyperprolactinemia in patients who have: * Failed to respond to a greater than or equal to 3 month trial of bromocriptine; or * Failed to tolerate bromocriptine; or * Failed to shrink a prolactinoma by greater than 1 cm after 12 months of bromocriptine therapy Coverage limit: LU Authorization Period: 5 years.
No interchangeable product listed in the Ontario extract
Norprolac · DIN 02223775 Manufacturer: Ferring Inc.; listing date 2006-10-23 Health Canada: Cancelled post market since 2021-06-02 · brand NORPROLAC · ATC G02CB04 QUINAGOLIDE · form Tablet · route Oral · ingredients QUINAGOLIDE (QUINAGOLIDE HYDROCHLORIDE) 0.15 MG · company Ferring inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Norprolac: Formulary list price $1.73 per unit (the source does not state the unit; exact figure $1.7294). What the ministry pays, not the patient.

Ministry pays: $1.7294 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02223775)

Source record
DIN 02223775: Norprolac Raw flags: sec12=Y, sec3=Y Item: 920000542; group id 950; item number 2257; lccId 00197; manufacturer id FEI Source form: Tab; strength: 0.15mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $1.7294; ministry $1.7294 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02223775 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=43392
Shortage status: discontinued (June 2, 2021, reported by FERRING INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02223775
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since June 2, 2021 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (G02CB): coverage varies; not interchangeable

  • Bromocriptine (Parlodel): general benefit, not a benefit
  • Cabergoline (Dostinex): limited Use 656
Other drugs in the same formulary class (92:00 UNCLASSIFIED THERAPEUTIC AGENTS) and how they are covered

Matched class: 92:00 UNCLASSIFIED THERAPEUTIC AGENTS

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ALENDRONATE & CHOLECALCIFEROL, AZATHIOPRINE, CYCLOSPORINE, GLUCAGON RDNA ORIGIN, LANREOTIDE ACETATE, LEFLUNOMIDE, LEVODOPA & BENSERAZIDE, MYCOPHENOLATE SODIUM, RISPERIDONE Some products covered without a code (check the product listing): ALENDRONATE, ALLOPURINOL, AMANTADINE HCL, BROMOCRIPTINE, CLOPIDOGREL BISULFATE, LEVODOPA & CARBIDOPA, MYCOPHENOLATE MOFETIL, OCTREOTIDE, RISEDRONATE SODIUM, ROPINIROLE, SELEGILINE HCL, TAMSULOSIN HCL 92:00 UNCLASSIFIED THERAPEUTIC AGENTS

BROMOCRIPTINE

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 5mg, 2.5mg · Cap, Tab

CABERGOLINE

· 3 products · Limited Use, codes 656 · strengths: 0.5mg · Tab

ALENDRONATE

· 28 products · Off-Formulary Interchangeable, not an ODB benefit (4), Listed, not a benefit (1), General benefit (23) · strengths: 5mg, 10mg, 70mg · Tab

ALENDRONATE & CHOLECALCIFEROL

· 6 products · General benefit · strengths: 70mg & 70mcg, 70mg & 140mcg · Tab

ALLOPURINOL

· 10 products · General benefit (6), Listed, not a benefit (4) · strengths: 100mg, 200mg, 300mg · Tab

AMANTADINE HCL

· 5 products · Listed, not a benefit (2), General benefit (3) · strengths: 100mg, 10mg/mL · Cap, O/L

AZATHIOPRINE

· 3 products · General benefit · strengths: 50mg · Tab

CLOPIDOGREL BISULFATE

· 19 products · General benefit (16), Off-Formulary Interchangeable, not an ODB benefit (3) · strengths: 75mg, 300mg · Tab

CYCLOSPORINE

· 8 products · General benefit · strengths: 10mg, 25mg, 50mg, 100mg, 100mg/mL · Cap, O/L

GLUCAGON RDNA ORIGIN

· 2 products · General benefit · strengths: 1mg/Vial · Inj Pd-Syr Pk, Inj Pd-Vial Pk

LANREOTIDE ACETATE

· 6 products · General benefit · strengths: 60mg/Syr, 90mg/Syr, 120mg/Syr · ER Pref Syr Pk

LEFLUNOMIDE

· 16 products · General benefit · strengths: 10mg, 20mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 92:00 and 78 more
Full class listing Related classes: Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no marketed product found

Availability

Norprolac · DIN 02223775 Shortage status: discontinued (2021-06-02, reported by FERRING INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02223775

Check this DIN again